AstraZeneca Publishes Phase III Data Showing Brezt...
Category : Clinical Trial Update 16 February 2026Full Phase III results from the KALOS and LOGOS trials, published in The Lancet Respiratory Medicine...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Novartis Reports Final Phase III ALIGN Data for Va...
Category : Clinical Trial Update 16 February 2026Novartis announced final results from the Phase III ALIGN study evaluating Vanrafia (atrasentan) in...
Aramis Biotechnologies Inc Completes Clinical Manu...
Category : Clinical Trial Update 16 February 2026Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) announced completion of formulat...
GLP-1 Receptor Agonists Linked to Reduced Asthma E...
Category : Product Related Updates 16 February 2026New real-world research presented at the AAAAI Annual Meeting suggests that glucagon-like peptide-1...
Chugai Presents Phase I/II Data on NXT007 Switch f...
Category : Clinical Trial Update 12 February 2026Chugai Pharmaceutical has presented new data from Part C of the Phase I/II NXTAGE study evaluating N...
Latest Newsletter Post
-
GLP-1 Receptor Agonists Linked to R..
16 February 2026
-
Aramis Biotechnologies Inc Complete..
16 February 2026
-
Novartis Reports Final Phase III AL..
16 February 2026
-
AstraZeneca Publishes Phase III Dat..
16 February 2026
-
Takeda’s Oveporexton Receives FDA P..
12 February 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com